News

Blood sample analysis showed that, two to five years after they gave birth, mothers of children with autism spectrum disorder (ASD) had several significantly different metabolite levels compared to mothers of typically developing children. That’s according to new research recently published in BMC Pediatrics by a multidisciplinary team from Rensselaer Polytechnic Institute, Arizona State University, and the Mayo Clinic.

TROY, N.Y. — Developing a physiological test for diagnosing autism spectrum disorder (ASD), one that measures certain components in the blood, has the potential to be a paradigm shift for diagnosing ASD. However, the large heterogeneity of how ASD affects individuals has long been viewed as a key obstacle to the development of such a test.

TROY, N.Y – Children with autism spectrum disorder (ASD) are often affected by co-occurring conditions, such as epilepsy, immune disorders, gastrointestinal problems, and developmental delays. According to research published today in Autism Research, creating a classification system for ASD based on co-occurring conditions could provide useful insights into the underlying mechanics of ASD and these conditions. 

TROY, N.Y. — Researchers at Rensselaer Polytechnic Institute who developed a blood test to help diagnose autism spectrum disorder have now successfully applied their distinctive big data-based approach to evaluating possible treatments.

A recent paper authored published in Research in Autism Spectrum Disorders discussed a test that can predict with approximately 90 percent accuracy whether a pregnant mother has a 1.7 percent or a tenfold increased risk of having a child diagnosed with ASD.

One year after researchers published their work on a physiological test for autism, a follow-up study confirms its exceptional success in assessing whether a child is on the autism spectrum.

An algorithm based on levels of metabolites found in a blood sample can accurately predict whether a child is on the Autism spectrum of disorder (ASD), based upon a recent study. 

New research shows that a single conserved mechanism governs the movement of two structurally distinct variants of kinesin-14 – a class of molecular motors that moves materials and facilitates chromosomal separation within cells. 

The Department of Biomedical Engineering at Rensselaer Polytechnic Institute will host the 41st Northeast Bioengineering Conference (NEBEC) April 17-19. 

Professor Juergen Hahn has received a $2 million NIH grant to investigate the use of transplanted regulatory T cells (Tregs) in reducing inflammation in diseases like inflammatory bowel disease, which currently has no known viable treatment options.